Treatment in Pregnancy for Hepatitis C (TiP-HepC) Clinical Case Registry

Created by the Coalition for Global Hepatitis Elimination a program of The Taskforce for Global Health

Direct-acting antiviral (DAA) medications have demonstrated excellent safety and efficacy in the treatment of hepatitis C virus (HCV) non-pregnant individuals, but there is a lack of data regarding the safety of these medications in pregnant women and the effectiveness of these medications in reducing mother-to-child transmission. This registry was created to record outcomes of mother-infant pairs exposed to DAAs during pregnancy. Findings from the registry will be critical to advancing HCV treatment decision-making by clinical providers and programs worldwide.